This study used data from six neuropsychological measures of executive function (EF) and general intellectual functioning (GIF) administered to 303 regular users of heroin and/or cocaine as indicators in a latent profile analysis (LPA). Results indicated the presence of three profiles: impaired GIF and EF profile (30.8%), intact GIF and EF profile (58.8%), and high GIF/intact EF profile (10.4%). Using a multinomial logistic regression, it was determined that individuals who reported being diagnosed with either a learning disability (LD) and/or attention-deficit/hyperactivity disorder (ADHD) were more likely to be in the impaired GIF and EF profile than other profiles. Results from a logistic regression indicated that the impaired GIF and EF profile was associated with a greater prevalence of past hepatitis B and/or C infection. Implication for harm reduction and treatment programs and the need to take into account individuals with LD and ADHD are discussed.
BeitchmanJ. H.WilsonB.DouglasL.YoungA.AdlafE. (2001). Substance use disorders in young adults with and without LD: Predictive and concurrent relationships. Journal of Learning Disabilities, 34, 317–332.
2.
BiedermanJ.WilensT. E.MickE.FaraoneS. V.SpencerT. (1998). Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?Biological Psychiatry, 44, 269–273.
3.
BollaK. I.FunderburkF. R.CadetJ. L. (2000). Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology, 54, 2285–2292.
4.
CosdenM. (2001). Risk and resilience for substance abuse among adolescents and adults with LD. Journal of Learning Disabilities, 34, 352–358.
5.
CulbertsonW. C.ZillmerE. A. (2001). Tower of London-Drexel (TOL-DX) technical manual. Odessa, FL: Psychological Assessment Resources.
6.
DencklaM. B. (1996). Biological correlates of learning and attention: What is relevant to learning disability and attention-deficit hyperactivity disorder?Journal of Developmental and Behavioral Pediatrics, 17, 114–119.
7.
Fals-StewartW. (1993). Neurocognitive defects and their impact on substance abuse treatment. Journal of Addictions & Offender Counseling, 13, 46.
8.
Fals-StewartW.LucenteS. (1994). Effect of neurocognitive status and personality functioning on length of stay in residential substance abuse treatment: An integrative study. Psychology of Addictive Behaviors, 8, 179.
9.
GarfeinR. S.VlahovD.GalaiN.DohertyM. C.NelsonK. E. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86, 655–661.
10.
GiancolaP. R.ParkerA. M. (2001). A six-year prospective study of pathways toward drug use in adolescent boys with and without a family history of a substance use disorder. Journal of Studies on Alcohol, 62, 166–178.
11.
GibsonW. A. (1959). Three multivariate models: Factor analysis, latent structure analysis and latent profile analysis. Psychometrika, 24, 229–252.
12.
GoldenC. J.FreshwaterS. M. (2002). The Stroop Color and Word Test: A manual for clinical and experimental uses. Chicago: Stoelting.
13.
GreenbergL. M.KindschiC. L.CormanC. L. (1999). TOVA Test of Variables of Attention: Clinical guide. Los Alimitos, CA: Universal Attention Disorders.
14.
HarrisJ.C. (1998). Developmental neuropsychiatry, Vol. 2: Assessment, diagnosis, and treatment of developmental disorders. 1995, New York, NY, US: Oxford University Press.
15.
HeatonR. K.CheluneG. J.TalleyJ. L.KayG. G.CurtissG. (1993). Wisconsin Card Sort Test manual: Revised and expanded. Odessa, FL: Psychological Assessment Resources.
16.
KuoI.ShermanS. G.ThomasD. L.StrathdeeS. A. (2004). Hepatitis B virus infection and vaccination among young injection and non-injection drug users: Missed opportunities to prevent infection. Drug and Alcohol Dependence, 73, 69–78.
17.
LazarJ. W.FrankY. (1998). Frontal systems dysfunction in children with attention-deficit/hyperactivity disorder and learning disabilities. Journal of Neuropsychiatry and Clinical Neuroscience, 10, 160–167.
18.
LevinF. R. (2007). Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. Journal of Clinical Psychiatry, 68(Suppl. 11), 9–14.
19.
LezakM. D. (2004). Neuropsychological assessment (4th ed.). Oxford, UK: Oxford University Press.
20.
McCoyC. B.LaiS.MetschL. R.MessiahS. E.ZhaoW. (2004). Injection drug use and crack cocaine smoking: Independent and dual risk behaviors for HIV infection. Annals of Epidemiology, 14, 535–542.
21.
MitchellM. M.SevertsonS. G.LatimerW. W. (2007). Interaction of cognitive performance and knowing someone who has died from AIDS on HIV risk behaviors. AIDS Education and Prevention, 19, 289–297.
22.
MoellerF. G.DoughertyD. M.BarrattE. S.SchmitzJ. M.SwannA. C.GrabowskiJ. (2001). The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance Abuse Treatment, 21, 193–198.
23.
NajamN.MossH. B.KirisciL.TarterR. E. (1997). Executive cognitive functioning predicts drug use in youth. Journal of the Indian Academy of Applied Psychology, 23, 3–12.
24.
NumminenH.ServiceE.AhonenT.KorhonenT.TolvanenA.PatjaK.. (2000). Working memory structure and intellectual disability. Journal of Intellectual Disability Research, 44, 579–590.
25.
NylundK.AsparouhovT.MuthenB. (2007) Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling: An Interdisciplinary Journal, 14, 535–569.
26.
ObrzutJ. E.HyndG. W.ObrzutA. (1983). Neuropsychological assessment of learning disabilities: A discriminant analysis. Journal of Experimental and Child Psychology, 35, 46–55.
27.
Office of National Drug Control. (2004). The economic costs of drug abuse in the United States, 1992-2002 (Publication No. 207303). Washington, DC: Executive Office of the President.
28.
ParaherakisA.CharneyD. A.GillK. (2001). Neuropsychological functioning in substance-dependent patients. Substance Use and Misuse, 36, 257–271.
29.
RothR. M.SaykinA. J. (2004). Executive dysfunction in attention-deficit/hyperactivity disorder: Cognitive and neuroimaging findings. Psychiatric Clinics in North America, 27, 83–96.
30.
RubinD. B. (1987). Multiple imputation for nonresponse in surveys. New York: John Wiley.
31.
SAMHSA. (2006). Results from the 2005 National Survey on Drug Use and Health: National findings. Washington, DC: Author.
32.
SeidmanL. J. (2006). Neuropsychological functioning in people with ADHD across the lifespan. Clinical Psychology Review, 26, 466–485.
33.
SevertsonS. G.LatimerW. W. (2006, June). Hepatitis C status among heroin and cocaine injection drug users: The role of intellectual function deficits. Poster presented at the CPDD Conference, Scottsdale, AZ.
34.
SevertsonS. G.MitchellM. M.ManchaB. E.LatimerW. W. (in press). The association between planning abilities and sharing injection drug use equipment among injection drug users in Baltimore, MD. Journal of Substance Use.
35.
SwansonH. L.Sachse-LeeC. (2001). Mathematical problem solving and working memory in children with learning disabilities: Both executive and phonological processes are important. Journal of Experimental Child Psychology, 79, 294–321.
36.
TapertS. F.BarattaM. V.AbrantesA. M.BrownS. A. (2002). Attention dysfunction predicts substance involvement in community youths. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 680–686.
37.
Verdejo-GarciaA.Lopez-TorrecillasF.GimenezC. O.Perez-GarciaM. (2004). Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychology Review, 14, 1–41.
38.
VikP. W.CellucciT.JarchowA.HedtJ. (2004). Cognitive impairment in substance abuse. Psychiatry Clinics of North America, 27, 97–109.
39.
WangC.-P.Hendricks BrownC.Bandeen-RocheK. (2005). Residual diagnostics for growth mixture models: Examining the impact of a preventive intervention on multiple trajectories of aggressive behavior. Journal of the American Statistical Association, 100, 1054–1076.
40.
WechslerD. (1997). WAIS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation.
41.
WestermeyerJ.KempK.NugentS. (1996). Substance disorder among persons with mild mental retardation: A comparative study. American Journal on Addictions, 5, 23–31.
42.
WestermeyerJ.PhaobtongT.NeiderJ. (1988). Substance use and abuse among mentally retarded persons: A comparison of patients and a survey population. American Journal of Drug and Alcohol Abuse, 14, 109–123.
43.
ZacharyR. A. (1991). The manual of the Shipley Institute of Living Scale. Los Angeles: Western Psychological Services.
